Literature DB >> 1751456

Randomised double-blind trial of bromovinyldeoxyuridine (BVDU) and trifluorothymidine (TFT) in dendritic corneal ulceration.

W J Power1, A Benedict-Smith, M Hillery, K Brady, L M Collum.   

Abstract

The results of a randomised double-blind clinical trial of 0.1% bromovinyldeoxyuridine (BVDU) and 1% trifluorothymidine (TFT) in 60 patients with corneal dendritic ulceration are presented. There was no significant difference between BVDU and TFT in terms of numbers of ulcers healed (p = 0.61), mean healing time (p = 0.065), and cumulative healing rate (p = 0.058). No serious side effects were observed, though transient stinging was recorded in five patients receiving TFT and in three patients receiving BVDU. One patient in the group treated with TFT developed a punctate epitheliopathy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1751456      PMCID: PMC1042518          DOI: 10.1136/bjo.75.11.649

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  12 in total

1.  Clinical evaluation of trifluorothymidine in the treatment of herpes simplex corneal ulcers.

Authors:  P C Wellings; P N Awdry; F H Bors; B R Jones; D C Brown; H E Kaufman
Journal:  Am J Ophthalmol       Date:  1972-06       Impact factor: 5.258

2.  (E)-5-(2-Bromovinyl)-2'-deoxyuridine: a potent and selective anti-herpes agent.

Authors:  E De Clercq; J Descamps; P De Somer; P J Barr; A S Jones; R T Walker
Journal:  Proc Natl Acad Sci U S A       Date:  1979-06       Impact factor: 11.205

3.  Bromovinyldeoxyuridine and interferon treatment in ulcerative herpetic keratitis: a double masked study.

Authors:  O P van Bijsterveld; P J Meurs; E de Clercq; P C Maudgal
Journal:  Br J Ophthalmol       Date:  1989-08       Impact factor: 4.638

4.  Oral acyclovir (Zovirax) in herpes simplex dendritic corneal ulceration.

Authors:  L M Collum; P McGettrick; J Akhtar; J Lavin; P J Rees
Journal:  Br J Ophthalmol       Date:  1986-06       Impact factor: 4.638

5.  Randomised double-blind trial of acyclovir and idoxuridine in dendritic corneal ulceration.

Authors:  L M Collum; A Benedict-Smith; I B Hillary
Journal:  Br J Ophthalmol       Date:  1980-10       Impact factor: 4.638

6.  (E)-5-(2-bromovinyl)-2'-Deoxyuridine in the treatment of experimental herpes simplex keratitis.

Authors:  P C Maudgal; E De Clercq; J Descamps; L Missotten; P De Somer; R Busson; H Vanderhaeghe; G Verhelst; R T Walker; A S Jones
Journal:  Antimicrob Agents Chemother       Date:  1980-01       Impact factor: 5.191

7.  Acyclovir (Zovirax) in herpetic disciform keratitis.

Authors:  L M Collum; P Logan; T Ravenscroft
Journal:  Br J Ophthalmol       Date:  1983-02       Impact factor: 4.638

8.  Efficacy of (E)-5-(2-bromovinyl)-2'-deoxyuridine in the topical treatment of herpes simplex keratitis.

Authors:  P C Maudgal; L Missotten; E De Clercq; J Descamps; E De Meuter
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1981

9.  Specific phosphorylation of E-5-(2-iodovinyl)-2'-deoxyuridine by herpes simplex virus-infected cells.

Authors:  J Descamps; E De Clercq
Journal:  J Biol Chem       Date:  1981-06-25       Impact factor: 5.157

10.  On the mechanism of selective inhibition of herpesvirus replication by (E)-5-(2-bromovinyl)-2'-deoxyuridine.

Authors:  H S Allaudeen; J W Kozarich; J R Bertino; E De Clercq
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

View more
  6 in total

Review 1.  Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis.

Authors:  Kirk R Wilhelmus
Journal:  Cochrane Database Syst Rev       Date:  2015-01-09

2.  ["Herpetic keratitis". Various expressions require different therapeutic approaches].

Authors:  B Seitz; A Heiligenhaus
Journal:  Ophthalmologe       Date:  2011-04       Impact factor: 1.059

Review 3.  Common ocular infections. A prescriber's guide.

Authors:  S P Donahue; J M Khoury; R P Kowalski
Journal:  Drugs       Date:  1996-10       Impact factor: 9.546

4.  In vitro synergism of trifluorothymidine and ganciclovir against HSV-1.

Authors:  Jeffery A Hobden; Manish Kumar; Herbert E Kaufman; Christian Clement; Emily D Varnell; Partha S Bhattacharjee; James M Hill
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-02-11       Impact factor: 4.799

5.  The treatment of herpes simplex virus epithelial keratitis.

Authors:  K R Wilhelmus
Journal:  Trans Am Ophthalmol Soc       Date:  2000

Review 6.  Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis.

Authors:  Kirk R Wilhelmus
Journal:  Cochrane Database Syst Rev       Date:  2010-12-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.